Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix to Receive $2M from US Defense Budget for Bio-Threat Projects

NEW YORK (GenomeWeb News) – CombiMatrix said today that the 2007 Defense Appropriations Bill, recently signed into law, includes two new allocations of $1 million each for the company’s development of microarray technologies for the detection of biological threat agents and infectious pathogens.

According to the company, one of the allocations was specifically granted to address concern over the Eurasian Avian Influenza A Virus, also known as H5N1.

“With this additional capital, our goal is to develop an integrated system that can be used in a laboratory as well as military and civilian environments where early detection can reduce the spread of the disease or the impact of a biothreat attack,” David Danley, director of CombiMatrix’s homeland defense unit, said in a statement.

 

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.